Toward an Optimal Procedure for Variable Selection and QSAR Model Building

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 3-6, 2001, Pages 1218-1227

  Yasri, A ^a   Hartsough, D ^a  

^a ARQULE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS (QSAR) TECHNIQUES;

CONFORMATIONS; DRUG PRODUCTS; GENETIC ALGORITHMS; NEURAL NETWORKS; REGRESSION ANALYSIS; TOPOLOGY;

MOLECULAR STRUCTURE;

BENZODIAZEPINE DERIVATIVE; BIOPOLYMER; TUBULIN;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; BENZODIAZEPINES; BIOPOLYMERS; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN;

EID: 0035438386     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010291a     Document Type: Article

References (56)

1. Hansch, C.; Muir, R. M.; Fujita, T.; Maloney, P. P.; Geiger, F.; Streich, M. The correlation of biological activity of plant growth regulators and chloromycetin derivatives with Hammett constants and partition coefficients. J. Am. Chem. Soc. 1963, 85, 2817-2824.
2. Hansh C.; Leo A. In Exploring QSAR: Fundamentals and applications in chemistry and biology; Heller S. R., Eds; American Chemical Society: Washington, DC, 1995.
3. Rekker, R. F. The Hydrophobic Fragmental Constants. Its Derivation and Application. A Means of Characterizing Membrane Systems. In Pharmacochemistry Library; Nauta, W. T., Rekker, R. F., Eds.; Elsevier: New York, 1977; Vol. 1.
4. Hall, L. H.; Kier, L. B. The molecular connectivity Chi Indexes and Kappa Shape Indexes in structure-Property Modeling. In Reviews in computational chemistry II; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: 1991; pp 367-422.
5. Exner, O. In Advances in Free Energy Relationships; Chapman, N. B., Shorter, J., Eds.; Plenum: New York, 1972; p 1.
6. Verloop, A.; Hoogenstraaten, W.; Tipker, J. In Drug Design; Ariens, E. J., Ed.; Academic Press: New York, 1976; Vol. VII, p 165.
7. Waller, C. L.; Bradley, M. P. Development and Validation of a novel variable selection technique with application to multidimensional quantitative structure-activity relationship studies. J. Chem. Inf. Comput. Sci. 1999, 39, 345-355.
8. Hall, L. H.; Kier, L. B. The molecular connectivity Chi Indexes and Kappa Shape Indexes in Structure-Property Modeling. In Review in Computational Chemistry II; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: 1991; pp 367-422.
9. Cramer, R. D.; Patterson, D, E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier oriteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
10. Shi, L. M.; Fan, Y.; Myers, T. G.; O'Connor, P. M.; Paull, K. D.; Friend, S. H.; Weinstein, J. N. Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues. J. Chem. Inf. Comput. Sci. 1998, 38, 2 189-99.
11. Partek Pro 2000. Partek Incorporated, Partek Analysis and Recognition technologies, Copyright 1993-1999.
12. Hasegawa, K.; Miyashita, Y.; Funatsu, K. GA strategy for variable selection in QSAR studies: GA-based PLS analysis of calcium channel antagonists. J. Chem. Inf. Comput. Sci. 1997, 37, 2, 306-310.
13. Hasegawa, K.; Miyashita, Y.; Funatsu, K. GA strategy for variable selection in QSAR studies: GA-PLS and D-optimal Designs for predcitive QSAR model. J. Mol. Struct. (THEOCHEM) 1998, 425, 255-262.
14. Cho SJ, Zheng W, Tropsha A. Rational combinatorial library design. 2. Rational design of targeted combinatorial peptide libraries using chemical similarity probe and the inverse QSAR approaches. J. Chem. Inf. Comput. Sci. 1998, 38, 2, 259-268.
15. Zheng W.; Tropsha, A. Novel Variable Selection Quantitative Structure-Property relationships approach based on the k-nearest neighbor principle. J. Inf. Comput. Sci. 2000, 40, 185-194.
16. So, S. S.; Karplus, M. Genetic Neural Networks for quantitative structure-activity relationships: improvement and application of Benzodiazepine affinity for Benzodiazepine/GABA A receptor. J. Med. Chem. 1996, 39, 5246-5256.
17. Topliss, J. G.; Edwards, R. P. Chance factors in Studies of quantitative Structure-Activity Relationships. J. Med. Chem. 1979, 22, 1238-1244.
18. Van de Waterbeemed, H. Chemometrics Methods in Molecular Design: Methods and principles in medicinal chemistry; VCH: Weinheim, 1995; Vol. 2.
19. Bentley, P. J. Evolutionary Design by computers; Morgan K. Publishers, Inc.: San Fracisco, CA, 1999.
20. Holland J. H. Genetic algorithms and Optimal allocations of trails. SIAM. J. Computing 1973, 2, 2, 88-105.
21. (21 ) Holland J. H. Adaptation in Natural and artificial systems: University of Mishigan Press: Ann Arbor, 1975.
22. Holland J. H. Genetic algorithms: Scientific American: 1992, 66-72.
23. Goldberg, D. E. Genetic algorithms in search, optimization and machine learning; Addison-Wesley: 1989.
24. Rumelhart, D. E.; Hinton G. E.; Williams R. J. Learning internal representations by error propagation. In Parallel Distributed Processing; Rumelhart, D. E., McClelland, J. L., and the PDP Research Group, Eds.; The MIT Press: Cambridge, MA, 1986; pp 318-362.
25. Weiss, S. M.; Kapouleas, I. An empirical comparison of pattern recognition, neural nets, and machine learning classification methods. In Proceedings of the Eleventh International Joint Conference on Artificial Intelligence (IJCAI-89); Detroit, MI, 1989; pp 781-787.
26. Moallemi, C. Classifying cells for cancer diagnosis using neural networks. IEEE EXPERT; 1991; pp 8-12.
27. Mooney, R.; Shavlik, J.; Towell, G.; Gove, A. An experimental comparison of symbolic and connectionist learning algorithms. In Proceedings of the Eleventh International Joint Conference on Artificial Intelligence (IJCAI-89); Detroit, MI, 1989; pp 775-780.
28. Hussain, A. S.; Yu, X.; Johnson R. D. Application of neural network computing in pharmaceutical product development. Pharm. Res. 1991, 8, 1248-1252.
29. Veng-Pedersen, P.; Modi, N. B. Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end? J. Pharmacokinet. Biopharm. 1992, 20, 397-412.
30. Erb, R. J. Neural network computation of nonlinear pharmacological effects from concentration of drug in the central compartment independent of equilibrium status. Pharm. Res. 1992, 9, 293.
31. Haefely, W.; Kyburz, E.; Gegecke, M; Möhloer, H. Recent advances in the molecular pharmacology of benzodiazepine receptors and the structure-activity relationships of their agonist and antagonists. Adv. Drug Res. 1985, 14, 165-322.
32. Weigt, M.; Weise M. A comparative Molecular Field Analysis of Inhibitors of Tubulin Polymerization. QSAR J. 19(2), 2000, 142-148.
33. Fahlman, S. E. In Faster-learning variations on back-propagation: An empirical study, Sejnowski, T. J., Hinton, G. E., Touretzky, D. S., Eds.: Connectionist Model Summer School, Morgan Kaufmann: San Mateo, CA, 1988.
34. Li,. L.; Wang, H. K.; Kuo, S. C.; Wu, T. S.; Lednicer, D.; Lin C. M.;. Hamel, E.; Lee, K. H. Antitumor agents 155, Synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents. J. Med. Chem. 1994, 37, 3400-3407.
35. Chen K.; Kuo, S. C.; Hsieh, M. C.; Mauger, A.; Lin C. M.; Hamel, E.; Lee, K.-H. Antitumor agents 174. 2′,3′,4′,5,6,7-substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J. Med. Chem. 1997, 40, 2266-2275.
36. Ajay, B. W. B.; Murcko, M. A. Designing libraries with CNS activity. J. Med. Chem. 1999, 42, 24 4942-51.
37. van de Waterbeemd, H.; Camenisch, G.; Folkers, G.; Chretien, J. R.; Raevsky, O. A. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug. Target. 1998, 6, 2, 151-65.
38. Fisher, H.; Gottschlich R.; Seeling A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 1998, 165, 3, 201-11.
39. Norinder, U.; Sjöberg, P.; Osterberg, T. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. J. Pharm. Sci. 1998, 87, 8, 952-959.
40. Molconn-Z, Molconn software 3.5; Lowell H. Hall, copyright 1998.
41. DiverseSolutions v 3.0.2, Distributed by Tripos, Inc. on behalf of the Laboratory of Molecular Graphics and theoretical Modeling, College of Pharmacy, University of Texas at Austin; Austin, TX, 1997.
42. MOE 2000.02. Molecular Operating Environment, Chemical Computing Group Inc.: Copyright 1997-2000.
43. PGAPack Parallel, Genetic Algorithm library, Nevine D., Mathematics and Computer Science Division at Argonne National Laboratory: Aragone, IL.
44. Malmgren, H. For classification and predictive purposes, simulated neural networks (SNNs; more often called artificial neural networks, ANNs) offer a powerful alternative to traditional statistical analyses [letter]. Epilepsia 1999, 40, 9, 1323-4.
45. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. Prediction of Human Intestinal Apsorption of Drugs Compounds from Molecular Structure J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
46. Bakken G. A.: Jurs P. C. Prediction of Hydroxyl radical rate constants from molecular structure. J. Chem. Inf. Comput. Sci. 1999, 39, 1064-1075.
47. Tetko, I. V.; Livingstone, D. J.; Luil, A. I. Neural Network studies. 1. Comparison of overfitting and overtraining. J. Chem. Inf. Comput. Sci. 1995, 35, 826-833.
48. Tetko, I. V.; Vila, A. E. P.; Livingstone, D. J.; Luil, A. I. Neural Network studies. 2. Variable Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 794-803.
49. A receptors using artificial neural networks. J. Med. Chem. 1995, 38, 4, 715-724.
50. Bono L.; Nenad T. Multivariate Regression Outperforms Several Robust Architectures of Neural Networks in QSAR Modeling. J. Chem. Inf. Comput. Sci. 1999, 39, 121-132.
51. Loew, G. H.; Nienow, J. R.; Poulsen, M. Theoretical structure-activity studies of benzodiazepine analogues. Mol. Pharmacol. 1984, 26, 19-34.
52. Greco, G.; Novellino, E,; Silipo, C.; Vittoria, A. Study of benzodiazepines receptor sites using a combined QSAR-CoMFA approach. Quant. Struct.-Act. Relat. 1992, 11, 461-477.
53. Ghose, A. K.; Crippen, G. M. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC. Mol Pharmacol. 1990, 37, 725-734.
54. Winkler, D. A.; Burden, F. R. Holographic QSAR of Benzodiazepines. QSAR J. 1998, 17, 224-231.
55. Winkler D. A.; Burden F. R.; Watkins A. J. R. Atomistic Topological Indices Applied to Benzodiazepines using Various Regression Methods. QSAR J. 1998, 17, 14-19.
56. Kovalishyn, V. V.; Tetko I. V.; Luik, A. I.; Kholodovych, V. V.; Villa, A. E. P.; Livingstone, D. J. Neural network studies. 3. Variable Selection in the cascade-correlation learning architecture. J. Chem. Inf. Comput. Sci. 1998, 38, 651-659.